US Broker Ratings

AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a Potential 109% Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector focusing on medical instruments and supplies, has been capturing investors’ attention with a promising potential upside of 109.05%. As..

Abivax SA (ABVX) Stock Analysis: A Biotech Gem with a 36.75% Potential Upside

Abivax SA (ABVX), a France-based biotechnology company, is capturing the attention of investors with its compelling growth potential and promising drug development pipeline. Currently trading at $69.56, Abivax offers a..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Company with a 251% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) presents a compelling opportunity for investors captivated by the potential for significant returns in the biotech sector. With a market capitalization of $545.62 million, this Pasadena-based..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 1.68% Upside Potential

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in senior housing communities across the United States. As demand..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Robust Revenue Growth Story with Strategic Potential

SIGA Technologies Inc. (NASDAQ: SIGA) stands out in the healthcare sector as a promising player in the drug manufacturing industry. With a focus on the health security market, SIGA’s leading..

Zevra Therapeutics, Inc. (ZVRA) Growth Potential: Analyst Ratings Signal 160.91% Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a commercial-stage biotechnology company headquartered in Celebration, Florida, is generating buzz among investors due to its significant growth potential. Specializing in the development of treatments..

Orthofix Medical Inc. (OFIX): Analyst Ratings Signal Potential 60.84% Upside for Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with a compelling potential upside of 60.84%, according..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Promising 184% Potential Upside for Biotech Enthusiasts

MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company, is capturing the attention of the investment community with its robust pipeline of precision peptide therapies aimed at tackling endocrine and metabolic..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Exploring a 17.92% Potential Upside in Gene Editing Solutions

Verve Therapeutics, Inc. (NASDAQ: VERV) is carving a niche in the biotechnology sector with its pioneering gene editing solutions aimed at treating cardiovascular diseases. Headquartered in Boston, Massachusetts, this clinical-stage..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Biotechnology Innovator Poised for 163% Upside According to Analyst Ratings

Investors in the healthcare sector always have a keen eye for biotech companies that promise groundbreaking innovations. Oruka Therapeutics, Inc. (NASDAQ: ORKA) is emerging as a compelling prospect, with a..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Eyeing a 16.53% Potential Upside in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With its headquarters in El Monte, California, the company has..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 152.67% Potential Upside with Innovative Cell Therapies

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering force in the healthcare sector, is making waves in the biotechnology industry with its innovative approach to cell engineering. The company is headquartered..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Unlocking 181% Potential Upside with Innovative Mental Health Treatments

Investors looking for a high-growth opportunity in the healthcare sector may find ATAI Life Sciences N.V. (NASDAQ: ATAI) an intriguing prospect. This Germany-based biotechnology firm is pioneering advancements in mental..

Valneva SE (VALN) Stock Analysis: A 29.58% Upside Potential in the Biotech Sector

Valneva SE (NASDAQ: VALN), a French biotechnology company, is making waves in the healthcare sector with its innovative approach to prophylactic vaccines. With a market capitalization of $933.35 million, Valneva..

RxSight, Inc. (RXST) Stock Analysis: Navigating the Healthcare Landscape with a Unique Innovation

RxSight, Inc. (NASDAQ: RXST), a trailblazer in the medical device industry, presents a fascinating case for investors looking to capitalize on groundbreaking technology in the healthcare sector. Specializing in light..

EyePoint Pharmaceuticals (EYPT) Stock Analysis: Exploring a 217% Potential Upside in Retinal Disease Therapeutics

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $747.86 million, this U.S.-based company is dedicated to..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating a 58.65% Potential Upside in the Biotech Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology sector, has been on investors’ radar due to its significant potential upside of 58.65%, as indicated by the..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring the 160% Potential Upside in Innovative Biotechnology

Arvinas, Inc. (NASDAQ: ARVN) stands at the forefront of biotechnology innovation, leveraging its pioneering PROTAC (Proteolysis Targeting Chimeras) technology to address some of the most challenging diseases. As a clinical-stage..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A Biotech Pioneer with Over 100% Upside Potential

AbCellera Biologics Inc. (NASDAQ: ABCL) is capturing investor attention with its impressive potential upside of over 100%, as analysts set an average price target of $9.29. This biotechnology company, headquartered..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: A Potential 43% Upside Opportunity in Healthcare Staffing

In the ever-evolving landscape of healthcare, Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a pivotal player, offering vital talent management services across the United States. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds